Medically eligible women who do not use HAART: The importance of abuse, drug use, and race

被引:130
作者
Cohen, MH
Cook, JA
Grey, D
Young, M
Hanau, LH
Tien, P
Levine, AM
Wilson, TE
机构
[1] Cook Cty Hosp, CORE Ctr, Bur Hlth Sci, Chicago, IL USA
[2] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA
[3] Georgetown Univ, Med Ctr, Dept Med, Washington, DC 20007 USA
[4] Montefiore Med Ctr, Dept Med, Bronx, NY 10467 USA
[5] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[6] San Francisco Dept Vet Affairs, San Francisco, CA USA
[7] Univ So Calif, Keck Sch Med, Div Hematol, Los Angeles, CA USA
[8] Suny Downstate Med Ctr, Dept Prevent Med & Community Hlth, Brooklyn, NY USA
关键词
D O I
10.2105/AJPH.94.7.1147
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives. We investigated the prevalence and characteristics of HIV-positive women who do not report highly active antiretroviral therapy (HAART) use. Methods. We analyzed HAART use among 1165 HIV-positive participants in the Women's Interagency HIV Study. Results. Between October 1, 2000, and March 31, 2001, 254 women with clinical indications for HAART reported not using it, 635 reported HAART use, and 276 had no clinical indications. In multivariate analysis, using crack/cocaine/heroin and a history of abuse decreased the likelihood of using HAART, whereas being White increased it. Conclusions. One of 4 women for whom HAART was indicated reported not using HAART. Childhood sexual abuse prevention, more intensive abuse treatment, and continuing drug treatment may enhance HIV disease treatment of women.
引用
收藏
页码:1147 / 1151
页数:5
相关论文
共 29 条
[1]   Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users [J].
Arnsten, JH ;
Demas, PA ;
Grant, RW ;
Gourevitch, MN ;
Farzodegan, H ;
Howard, AA ;
Schoenboum, EE .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 (05) :377-381
[2]   The Women's Interagency HIV Study [J].
Barkan, SE ;
Melnick, SL ;
Preston-Martin, S ;
Weber, K ;
Kalish, LA ;
Miotti, P ;
Young, M ;
Greenblatt, R ;
Sacks, H ;
Feldman, J .
EPIDEMIOLOGY, 1998, 9 (02) :117-125
[3]  
Bassetti S, 1999, J ACQ IMMUN DEF SYND, V21, P114
[4]  
Bogart LM, 2000, J ACQ IMMUN DEF SYND, V23, P396
[5]   Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel [J].
Carpenter, CCJ ;
Cooper, DA ;
Fischl, MA ;
Gatell, JM ;
Gazzard, BG ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schechter, M ;
Schooley, RT ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (03) :381-390
[6]  
Centers for Disease Control and Prevention, 2001, HIV AIDS SURVEILLANC, V13, P1
[7]   Domestic violence and childhood sexual abuse in HIV-infected women and women at risk for HIV [J].
Cohen, M ;
Deamant, C ;
Barkan, S ;
Richardson, J ;
Young, M ;
Holman, S ;
Anastos, K ;
Cohen, J ;
Melnick, S .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2000, 90 (04) :560-565
[8]   Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy [J].
Cohen, MH ;
French, AL ;
Benning, L ;
Kovacs, A ;
Anastos, K ;
Young, M ;
Minkoff, H ;
Hessol, NA .
AMERICAN JOURNAL OF MEDICINE, 2002, 113 (02) :91-98
[9]  
Cook JA, 2002, J ACQ IMMUN DEF SYND, V30, P401, DOI [10.1097/00042560-200208010-00005, 10.1097/01.QAI.0000018280.16783.FE]
[10]   Use of highly active antiretroviral therapy in a cohort of HIV-seropositive women [J].
Cook, JA ;
Cohen, MH ;
Grey, D ;
Kirstein, L ;
Burke, J ;
Anastos, K ;
Palacio, H ;
Richardson, J ;
Wilson, TE ;
Young, M .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2002, 92 (01) :82-87